Longitudinal brain structural changes in preclinical Alzheimer's disease

Abstract
Our longitudinal data confirm a biphasic trajectory of changes in brain structure in preclinical AD. These have implications in AD trials, both in patient selection and the use of MRI as a surrogate marker of efficacy.
Funding Information
  • European Regional Development Fund
  • Alzheimer's Disease Neuroimaging Initiative
  • National Institutes of Health (U01 AG024904)
  • U.S. Department of Defense (W81XWH‐12‐2‐0012)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering